Log in or Sign up for Free to view tailored content for your specialty!
Diabetes News
Francis S. Collins: Genetic data poised to revolutionize landscape of diabetes care
SAN DIEGO — Genetic data gleaned from an ongoing “-omics” revolution are providing new insights for the prevention and treatment of diabetes that will dramatically change clinical care within the next 10 years, according to a speaker.
VIDEO: ADA president discusses 2023 meeting, improving diabetes care, and more
SAN DIEGO — In this video exclusive, Rodica Pop-Busui, MD, PhD, American Diabetes Association president, describes initiatives for her term, including an end to amputations and improved access to care.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: ADA award winner calls perseverance, collaboration critical to science
The keys to scientific achievement are perseverance and collaboration, according to Raghavendra G. Mirmira, MD, PhD, who said those qualities combined to make the moon landing “perhaps the greatest” human accomplishment.
SURMOUNT 2, OASIS 1 and other trial symposia lead program at ADA Scientific Sessions
Findings from several pivotal trials, including SUMOUNT-2, OASIS-1 and PIONEER PLUS, will be among the many highlights at the American Diabetes Association’s 83rd Scientific Sessions beginning Friday.
Higher time in range reduces risks for CV events, severe hypoglycemia in type 2 diabetes
People with type 2 diabetes who spend more time in glycemic range have lower risks for major adverse cardiovascular events, severe hypoglycemia and microvascular events, according to a post hoc analysis of the DEVOTE trial.
FDA approves empagliflozin for use among children with type 2 diabetes
The FDA has approved two forms of empagliflozin as an adjunct to diet and exercise to improve glycemic control in children with type 2 diabetes, according to a press release.
Boston, Cincinnati children’s hospitals share top ranking for pediatric endocrinology
Boston Children’s Hospital and Cincinnati Children’s Hospital Medical Center have both been named co-No. 1 hospitals for pediatric diabetes and endocrinology, according to the U.S. News & World Report.
Closed-loop systems linked to higher time in range for children with type 1 diabetes
CHICAGO — Children with type 1 diabetes using closed-loop insulin delivery systems spend more time in range than those receiving insulin injections or using a sensor-augmented pump or continuous glucose monitor, according to study data.
Meta-analysis confirms benefits of SGLT2 inhibitors in various high-risk populations
SGLT2 inhibitors reduce risk for CV death and HF events in patients with any or multiple of HF, type 2 diabetes and chronic kidney disease, according to a meta-analysis published in the Journal of the American College of Cardiology.
Providing diabetes care that does not meet guidelines increases health costs for patients
Patients with diabetes who received care that did not adhere to the American Diabetes Association, or ADA, guidelines spent an extra $4,031 in annual health care costs compared with the prior year, a recent study found.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read